MP34-16 FACILITY LEVEL VARIATION IN RATES OF DEFINITIVE THERAPY FOR LOW RISK PROSTATE CANCER AMONG MEN WITH LIMITED LIFE EXPECTANCY: AN OPPORTUNITY FOR VALUE-BASED CARE REDESIGN | Zendy

AI Assistant Blog Pricing

MP34-16 FACILITY LEVEL VARIATION IN RATES OF DEFINITIVE THERAPY FOR LOW RISK PROSTATE CANCER AMONG MEN WITH LIMITED LIFE EXPECTANCY: AN OPPORTUNITY FOR VALUE-BASED CARE REDESIGN

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.